ask="N/A"
ask_size="N/A"
average_daily_volume="1098200"
bid="N/A"
bid_size="N/A"
book_value="4.05"
change="N/A"
change_from_200_day_moving_average="-4.14"
change_from_50_day_moving_average="0.69"
change_from_52_week_high="-13.01"
change_From_52_week_low="9.96"
change_in_percent="N/A"
close="42.14"
dividend_pay_date="N/A"
dividend_per_share="0.00"
dividend_yield="0.00"
earnings_per_share="-1.45"
ebitda="-134.59M"
eps_estimate_current_year="-1.68"
eps_estimate_next_quarter="-0.48"
eps_estimate_next_year="-2.05"
ex_dividend_date="N/A"
float_shares="85678000"
high="N/A"
high_52_weeks="55.15"
last_trade_date="2/13/2017"
last_trade_price="42.14"
last_trade_size="N/A"
last_trade_time="4:00pm"
low="N/A"
low_52_weeks="32.18"
market_capitalization="3.66B"
moving_average_200_day="46.28"
moving_average_50_day="41.45"
name="Neurocrine Biosciences
Inc."
notes="N/A"
one_year_target_price="67.00"
open="N/A"
pe_ratio="N/A"
peg_ratio="0.69"
percent_change_from_200_day_moving_average="-8.95%"
percent_change_from_50_day_moving_average="+1.66%"
percent_change_from_52_week_high="-23.59%"
percent_change_from_52_week_low="+30.95%"
previous_close="42.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="10.41"
price_per_sales="244.05"
revenue="15.00M"
shares_outstanding="86871000"
short_ratio="3.01"
stock_exchange="NMS"
symbol="NBIX"
volume="0"
weeks_range_52="32.18 - 55.15"
